as 09-10-2025 4:00pm EST
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | ANDOVER |
Market Cap: | 3.9B | IPO Year: | 2019 |
Target Price: | $122.11 | AVG Volume (30 days): | 934.4K |
Analyst Decision: | Buy | Number of Analysts: | 10 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.02 | EPS Growth: | 2163.11 |
52 Week Low/High: | $55.00 - $169.29 | Next Earning Date: | 10-27-2025 |
Revenue: | $531,292,000 | Revenue Growth: | 48.09% |
Revenue Growth (this year): | 38.86% | Revenue Growth (next year): | 20.79% |
TMDX Breaking Stock News: Dive into TMDX Ticker-Specific Updates for Smart Investing
Motley Fool
2 months ago
Simply Wall St.
2 months ago
Zacks
2 months ago
Insider Monkey
3 months ago
Simply Wall St.
3 months ago
Simply Wall St.
3 months ago
Simply Wall St.
3 months ago
Simply Wall St.
3 months ago
The information presented on this page, "TMDX TransMedics Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.